A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Applying to NYU Langone Medical Center · New York, New York
Answer a few short questions to share with the research team.